NO20064057L - Metode for a stimulere harvekst - Google Patents

Metode for a stimulere harvekst

Info

Publication number
NO20064057L
NO20064057L NO20064057A NO20064057A NO20064057L NO 20064057 L NO20064057 L NO 20064057L NO 20064057 A NO20064057 A NO 20064057A NO 20064057 A NO20064057 A NO 20064057A NO 20064057 L NO20064057 L NO 20064057L
Authority
NO
Norway
Prior art keywords
growth
harrow
stimulate
dihydro
oxopyridazin
Prior art date
Application number
NO20064057A
Other languages
English (en)
Norwegian (no)
Inventor
Niall Stephen Doherty
Dennis Allen Smith
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of NO20064057L publication Critical patent/NO20064057L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14Oxygen atoms
    • C07D237/16Two oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines
    • A61K31/501Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/14Drugs for dermatological disorders for baldness or alopecia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20064057A 2004-02-12 2006-09-08 Metode for a stimulere harvekst NO20064057L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54411604P 2004-02-12 2004-02-12
PCT/IB2005/000257 WO2005079804A1 (en) 2004-02-12 2005-02-01 Method of stimulating hair growth

Publications (1)

Publication Number Publication Date
NO20064057L true NO20064057L (no) 2006-11-08

Family

ID=34886004

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20064057A NO20064057L (no) 2004-02-12 2006-09-08 Metode for a stimulere harvekst

Country Status (15)

Country Link
US (2) US20050182065A1 (pt)
EP (1) EP1715869A1 (pt)
JP (1) JP2007522201A (pt)
KR (1) KR100802848B1 (pt)
CN (1) CN1917878A (pt)
AR (1) AR050574A1 (pt)
AU (1) AU2005215258A1 (pt)
BR (1) BRPI0507669A (pt)
CA (1) CA2555741C (pt)
IL (1) IL177001A0 (pt)
NO (1) NO20064057L (pt)
RU (1) RU2006129320A (pt)
TW (1) TW200526222A (pt)
WO (1) WO2005079804A1 (pt)
ZA (1) ZA200606428B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6733714B2 (en) * 2001-08-13 2004-05-11 Edwin J. Oakey Method for forming high-impact, transparent, distortion-free polymeric material
WO2004043424A1 (en) * 2002-11-12 2004-05-27 Warner-Lambert Company Llc Method of stimulating hair growth using benzopyrans
BRPI0512708A (pt) * 2004-07-16 2008-04-01 Warner Lambert Co agentes promotores de crescimento de cabelo
JP2008506767A (ja) * 2004-07-19 2008-03-06 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー 発毛を刺激する製剤
WO2011103624A1 (en) * 2010-02-24 2011-09-01 Advangen International Pty Ltd Method of treatment or prevention of hair loss or for the enhancement of hair growth

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL108841A0 (en) * 1993-03-10 1994-06-24 Pfizer Res & Dev Benzopyrans
GB9316111D0 (en) * 1993-08-04 1993-09-22 Pfizer Ltd Benzopyrans
US5547957A (en) * 1993-10-15 1996-08-20 Merck & Co., Inc. Method of treating androgenic alopecia with 5-α reductase inhibitors
WO2004043424A1 (en) * 2002-11-12 2004-05-27 Warner-Lambert Company Llc Method of stimulating hair growth using benzopyrans

Also Published As

Publication number Publication date
WO2005079804A1 (en) 2005-09-01
IL177001A0 (en) 2006-12-10
CN1917878A (zh) 2007-02-21
ZA200606428B (en) 2008-01-30
KR100802848B1 (ko) 2008-02-12
BRPI0507669A (pt) 2007-07-17
KR20060114005A (ko) 2006-11-03
US20090143393A1 (en) 2009-06-04
US20050182065A1 (en) 2005-08-18
JP2007522201A (ja) 2007-08-09
WO2005079804A8 (en) 2006-05-18
TW200526222A (en) 2005-08-16
AU2005215258A1 (en) 2005-09-01
CA2555741C (en) 2010-03-23
CA2555741A1 (en) 2005-09-01
EP1715869A1 (en) 2006-11-02
RU2006129320A (ru) 2008-02-27
AR050574A1 (es) 2006-11-08

Similar Documents

Publication Publication Date Title
WO2005030791A3 (en) Isoquinolinone potassium channel inhibitors
EA200701439A1 (ru) Pyy-агонисты и их применение
WO2005030129A3 (en) Quinoline potassium channel inhibitors
WO2005046578A3 (en) Isoquinolinone potassium channel inhibitors
WO2006026617A3 (en) Compositions and methods of promoting hair growth
ZA200305860B (en) Composition for heart disease, method to prepare same and uses thereof.
PL370310A1 (en) Method of improving the growth performance of an animal
WO2006015159A3 (en) Potassium channel inhibitors
BR0307312B1 (pt) parque eólico, e, processo para o controle do teleférico.
FI20010847L (fi) Kuiturata ja menetelmä sen valmistamiseksi
WO2005016883A3 (en) Acrylamide derivatives as vla-1 integrin antagonists and uses thereof
IS7402A (is) Ný kristölluð form atorvastatínhálfkalsíums og aðferðir til að framleiða þau, auk nýrra aðferða tilað framleiða atorvastatínhálfkalsíum form I, VIIIog IX
EG25315A (en) Methods for improving growth and crop productivityof plants by adjusting plant hormone levels, rati os and/or co-factors.
EP1667685A4 (en) -QUINAZOLINE-POTASSIUM CHANNEL INHIBITORS
ATE476419T1 (de) Isochinolinon-kaliumkanalinhibitoren
NO20064057L (no) Metode for a stimulere harvekst
AU2002252029A1 (en) High oil maize plants, and methods for obtaining same
ATE323677T1 (de) Verfahren zur herstellung von 4-amino-2,5- bisheterocyclylchinazolinen
BR0208000B1 (pt) composiÇÕes fungicidas, processo de controle dos fungos fitopatogÊnicos das culturas e produto.
FI20020088L (fi) Menetelmä kasvislignaanien valmistamiseksi ja uusi välituote
BR0209697B1 (pt) processo de fabricaÇço de cerveja.
NO20041437L (no) Fremgangsmate for forbedring av jord ved bio-eksplosjon og tilveiebringelse av mikroorganismer for dette.
ITMI20030444A1 (it) Processo per preparare (per)fluoroalogenoeteri.
EA200701852A1 (ru) Производные аминокислот
EA200801573A1 (ru) Способ получения кристаллических форм орлистата

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application